Literature DB >> 10196286

Role of cellular tumor necrosis factor receptor-associated factors in NF-kappaB activation and lymphocyte transformation by herpesvirus Saimiri STP.

H Lee1, J K Choi, M Li, K Kaye, E Kieff, J U Jung.   

Abstract

The STP oncoproteins of the herpesvirus saimiri (HVS) subgroup A strain 11 and subgroup C strain 488 are now found to be stably associated with tumor necrosis factor receptor-associated factor (TRAF) 1, 2, or 3. Mutational analyses identified residues of PXQXT/S in STP-A11 as critical for TRAF association. In addition, a somewhat divergent region of STP-C488 is critical for TRAF association. Mutational analysis also revealed that STP-C488 induced NF-kappaB activation that was correlated with its ability to associate with TRAFs. The HVS STP-C488 P10-->R mutant was deficient in human T-lymphocyte transformation to interleukin-2-independent growth but showed wild-type phenotype for marmoset T-lymphocyte transformation in vitro and in vivo. The STP-C488 P10-->R mutant was also defective in Rat-1 fibroblast transformation, and fibroblast cell transformation was blocked by a TRAF2 dominant-negative mutant. These data implicate TRAFs in STP-C488-mediated transformation of human lymphocytes and rodent fibroblasts. Other factors are implicated in immortalization of common marmoset T lymphocytes and may also be critical in the transformation of human lymphocytes and rodent fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196286      PMCID: PMC104169     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Involvement of CRAF1, a relative of TRAF, in CD40 signaling.

Authors:  G Cheng; A M Cleary; Z S Ye; D I Hong; S Lederman; D Baltimore
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

2.  A novel RING finger protein interacts with the cytoplasmic domain of CD40.

Authors:  H M Hu; K O'Rourke; M S Boguski; V M Dixit
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

3.  Improved recombinant PCR mutagenesis procedure that uses alkaline-denatured plasmid template.

Authors:  Z Du; D A Regier; R C Desrosiers
Journal:  Biotechniques       Date:  1995-03       Impact factor: 1.993

4.  Association of the viral oncoprotein STP-C488 with cellular ras.

Authors:  J U Jung; R C Desrosiers
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

5.  Virus-encoded cyclin.

Authors:  J U Jung; M Stäger; R C Desrosiers
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

6.  Distinct functional domains of STP-C488 of herpesvirus saimiri.

Authors:  J U Jung; R C Desrosiers
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

7.  Epithelial tumours induced by a herpesvirus oncogene in transgenic mice.

Authors:  C Murphy; C Kretschmer; B Biesinger; J Beckers; J Jung; R C Desrosiers; H K Müller-Hermelink; B W Fleckenstein; U Rüther
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867

8.  The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family.

Authors:  G Mosialos; M Birkenbach; R Yalamanchili; T VanArsdale; C Ware; E Kieff
Journal:  Cell       Date:  1995-02-10       Impact factor: 41.582

9.  A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor.

Authors:  M Rothe; S C Wong; W J Henzel; D V Goeddel
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

10.  Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri.

Authors:  R P Rother; S A Rollins; W L Fodor; J C Albrecht; E Setter; B Fleckenstein; S P Squinto
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

View more
  24 in total

Review 1.  Signaling activities of gammaherpesvirus membrane proteins.

Authors:  B Damania; J K Choi; J U Jung
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 2.  Evolutionary aspects of oncogenic herpesviruses.

Authors:  J Nicholas
Journal:  Mol Pathol       Date:  2000-10

3.  The collagen repeat sequence is a determinant of the degree of herpesvirus saimiri STP transforming activity.

Authors:  J K Choi; S Ishido; J U Jung
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Distinctive features of large complex virus genomes and proteomes.

Authors:  Jan Mrázek; Samuel Karlin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-09       Impact factor: 11.205

5.  Activation of the STAT6 transcription factor in Jurkat T-cells by the herpesvirus saimiri Tip protein.

Authors:  Yuri Kim; Eun-Kyung Kwon; Ju-Hong Jeon; Insuk So; In-Gyu Kim; Myung-Sik Choi; Ik-Sang Kim; Joong-Kook Choi; Jae Ung Jung; Nam-Hyuk Cho
Journal:  J Gen Virol       Date:  2011-10-19       Impact factor: 3.891

6.  A novel TNF receptor-associated factor 6 binding domain mediates NF-kappa B signaling by the common cytokine receptor beta subunit.

Authors:  Mark B Meads; Zhi-Wei Li; William S Dalton
Journal:  J Immunol       Date:  2010-07-09       Impact factor: 5.422

Review 7.  Simian homologues of human herpesvirus 8.

Authors:  B Damania; R C Desrosiers
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

Review 8.  Herpesvirus saimiri.

Authors:  H Fickenscher; B Fleckenstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

9.  Activation of NF-κB by the Kaposi's sarcoma-associated herpesvirus K15 protein involves recruitment of the NF-κB-inducing kinase, IκB kinases, and phosphorylation of p65.

Authors:  Anika Hävemeier; Silvia Gramolelli; Marcel Pietrek; Ramona Jochmann; Michael Stürzl; Thomas F Schulz
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

10.  Herpesvirus ateles Tio can replace herpesvirus saimiri StpC and Tip oncoproteins in growth transformation of monkey and human T cells.

Authors:  Jens-Christian Albrecht; Brigitte Biesinger; Ingrid Müller-Fleckenstein; Doris Lengenfelder; Monika Schmidt; Bernhard Fleckenstein; Armin Ensser
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.